Cameco is trading 4% down at CA$129.78 after investors continued weighing weaker second-quarter performance.
- Reported $25 million in net earnings, $77 million in adjusted net earnings, and $391 million in adjusted EBITDA.
- Uranium-segment EBITDA declined year over year amid lower planned sales deliveries, despite a new long-term uranium supply agreement with India.
- Lower U.S. equities are adding pressure to risk-sensitive shares.